Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neonatal European Study of Inhaled Steroids
ISRCTN80181452Phase 3Completed
- Sponsor
- University Children's Hospital Tübingen
- Start
- Apr 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in bronchopulmonary dysplasia (BPD) comparing Inhaled budesonide with Placebo (2 arms). Primary endpoint: Composite of bronchopulmonary dysplasia or death. Started Apr 2010; status: completed.
02
Drugs
budesonide
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on ISRCTN80181452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN80181452.